StonvexLoading…
StonvexStonvexStonvexCore line items from PRGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $969.20M | $4.25B | $3.14B | $2.10B |
Operating Income | $-372.30M | $-1.12B | $164.90M | $92.30M |
Net Income | $-398.60M | $-1.43B | $-7.30M | $-8.40M |
EPS (Diluted) | $-2.87 | $-10.29 | $-0.05 | $-0.10 |
Total Assets | $7.98B | $8.54B | $10.08B | $10.09B |
Total Liabilities | $5.48B | $5.60B | $5.64B | $5.62B |
Cash & Equivalents | $357.20M | $531.60M | $432.10M | $454.20M |
Free Cash Flow OCF − CapEx | $-127.40M | $145.10M | $-3.50M | $-33.30M |
Shares Outstanding | 138.10M | 137.60M | 137.60M | 137.60M |